Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients. uri icon

authors

  • Arisi, Ivan
  • Malerba, Francesca
  • Florio, Rita
  • Pascale, Esterina
  • Hermona Soreq, PhD
  • Salvetti, Marco
  • Cattaneo, Antonino
  • D'Onofrio, Mara
  • Conte, Antonella
  • Malimpensa, Leonardo
  • Manzini, Valeria
  • Brandi, Rossella
  • Gosetti di Sturmeck, Tommaso
  • D'Amelio, Chiara
  • Crisafulli, Sebastiano
  • Ferrazzano, Gina
  • Belvisi, Daniele

publication date

  • December 13, 2023